HYDERABAD, India--GVK Biosciences Pvt. Ltd., a leading provider of databases and services to the Life Sciences industry, has selected GGA as its distributor for its Informatics Database products and services in Taiwan.
"Genesis Genetics Asia Corp. is recognized as the premier distributor in the Life Sciences industry in Taiwan and we are pleased to work with a high caliber sales team that will help expand our customer base in the region," said Sreeni Devidas, Vice President, Business Development, Informatics, GVK Biosciences Pvt. Ltd. "GGA will be responsible for distribution of the SAR, Biomarker and Clinical Outcomes databases and would also promote the BioIT and Data Curation services offered by GVK BIO."
"GVK BIO's comprehensive products and superior BioIT services are powerful additions to GGA's portfolio in informatics business. We are pleased to become GVK BIO's distribution partner as it will enable our company to provide researchers in the Taiwanese pharma-biotech industries with such great tools," said Dr. Pei-Li Li, Vice President, Molecular Science Center, Genesis Genetics Asia Corp. "The ability to search for the desired biomarkers; make queries and compare drug structures and activities; analyze, design and predict the successful outcome in clinical trials will give impetus to Taiwan's pharmaceutical industry in progressing ahead."
About GVK Biosciences Pvt Ltd
GVK Biosciences (GVK BIO) is Asia's leading Discovery, Research and Development organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services comprise of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO's diverse portfolio and prestigious clientele comprising of more than 200 customers includes some of the world's largest pharmaceutical, biotechnology, agro, life-sciences companies and leading academic institutions. Please visit us at www.gvkbio.com to know more.
Genesis Genetics Asia Corp. (GGA) (TPO:4160) is one of the premier genetic diagnosis and research hubs in Asia and a leading scientific informatics solution provider in Taiwan. Armed with cutting-edge diagnostic technologies, GGA's genetics lab has helped free many new-born babies from incurable genetic disorder diseases. GGA's informatics business arm, Molecular Science Center (MSC), has been progressing further in pharma-biotech research using advanced scientific informatics technologies and premium contents in Taiwan as well as in other Asia Pacific countries since 2004. Together GGA's wet and dry labs aim to help discover the causes and the relevant solutions for improving the quality of life.